Companies: 10,795·Total market cap: $144.5T
Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.

CARMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4185
P/E Ratio—
52W High$1.27
52W Low$0.0001
Overview

Carisma Therapeutics, Inc. (CARM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CARM · as of Mar 31, 2025

Latest filing snapshot

46
-61-57.01%vs prior year

Carisma Therapeutics, Inc. (CARM) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
46
Change (1Y)
-61
Growth % (1Y)
-57.01%
Revenue / Employee
$426.8K
Net Income / Employee
$-1.31M
Market Cap
$0M

CARM Employee Count

2023 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-03-3146-61-57.01%
2024-04-01107——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Jasper Therapeutics, Inc.
JSPR
Jasper Therapeutics, Inc.
64#2
Carisma Therapeutics, Inc.
CARM
Carisma Therapeutics, Inc.YOU
46#3
Onconetix, Inc.
ONCO
Onconetix, Inc.
12#4
Indaptus Therapeutics, Inc.
INDP
Indaptus Therapeutics, Inc.
7#5
CDT Equity Inc.
CDT
CDT Equity Inc.
6#6
Enveric Biosciences, Inc.
ENVB
Enveric Biosciences, Inc.
5#7
Aspire Biopharma Holdings, Inc.
ASBP
Aspire Biopharma Holdings, Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CARM peer comparison

About CARM employees

CARM Employees · Headcount

Carisma Therapeutics, Inc. (CARM) employee data is sourced from the annual SEC 10-K filing. As of 2024, Carisma Therapeutics, Inc. had 46 full-time employees globally. Full-time employees only. Global consolidated headcount.

Carisma Therapeutics, Inc. employs 46 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $426,783, reflecting the company's operational efficiency.

Carisma Therapeutics, Inc.'s workforce decreased by 61 (57.01%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Carisma Therapeutics, Inc.'s revenue per employee of $426,783 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

CARM Employees · 5 questions

As of the latest SEC 10-K filing (2024), Carisma Therapeutics, Inc. had 46 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Carisma Therapeutics, Inc. employee counthow many employees does Carisma Therapeutics, Inc. haveCARM total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-31